A just-posted trial notification shows very early clinical trials by Allergan, for their product they have named AGN-199201. The double blind trial will compare 3 different formulations of AGN-199201 with with the vehicle. The decrease in redness …
April 19th, 2012, by David Pascoe | allergan, clinical trials, red face
A just-posted trial notification shows very early clinical trials by Allergan, for their product they have named AGN-199201. The double blind trial will compare 3 different formulations of AGN-199201 with with the vehicle. The decrease in redness …
April 9th, 2012, by David Pascoe | clinical trials, galderma, ivermectin
The mysterious CD5024 1% Cream for which Galderma is conducting a large Phase III trial, has further been confirmed as the anti-parasitic Ivermectin.
This latest confirmation comes from the World Heath Organisation’s International Clinical Trials Registry Platform Search Portal. The search for CD5024 reveals trials that have completed in the Czech Republic, Germany and Hungary. The register was created in 2006, the same year as when …
March 21st, 2012, by David Pascoe | clinical trials, tetracyclines, topicals
A recent press release teases rosacea sufferers that a topical foaming form of minocycline might become a new treatment. The trial results promoted in the press release are for a condition called Impetigo, …
March 13th, 2012, by David Pascoe | acne treatments, clinical trials, topicals
In January 2009 we learnt that Medicis was interested in trialing Ziana as a treatment for rosacea. Medicis may be known to rosacea sufferers because they also make Plexion and Solodyn. Sadly the rigorous nature …
February 17th, 2012, by David Pascoe | clinical trials, galderma, ivermectin, metrogel
A large study looking at a treatment for the papules and pustules of rosacea is looking to recruit participants right across the US and Canada.
A web site just for this study has been created at www.pprstudy.com (Papulo – Pustular – Rosacea Study). On the site you can use your ZIP code to see …